Jean-Cosme Dodart | SVP of Preclinical R&D at Vaxxinity
vaxxinity

Jean-Cosme Dodart, SVP of Preclinical R&D at Vaxxinity, vaxxinity

Jean-Cosme (JC) Dodart is SVP of Preclinical R&D at Vaxxinity. JC has over 20+ years of experience in Neuroscience drug discovery at both large Pharma (Lilly, Merck, Novartis) and small Biotech (Sage Therapeutics, Wave Life Sciences). He has a strong track record of success in drug discovery and has worked in many neuroscience disease areas including Alzheimer’s disease, neuromuscular disorders, pain and depression. Many of the pre-clinical projects that JC has worked on have made it into clinical testing including several promising drug candidates that are currently in clinical trials. JC earned a M.S. degree in cell biology and physiology from University Pierre & Marie Curie in Paris and a Ph.D. degree in neuroscience from University Louis Pasteur, Strasbourg, France.

Appearances:



Festival of Biologics Day 2 @ 11:50

Active immunization against a-synuclein for the prevention and treatment of Parkinson’s disease and other synucleopathies

  • Vaxxinity’smodular vaccine platform
  • Preclinical evidence supporting UB-312 as a candidate vaccine
  • Safety and immunogenicity of UB-312 in healthy individuals
last published: 17/Sep/21 16:05 GMT
last published: 17/Sep/21 16:05 GMT
last published: 17/Sep/21 16:05 GMT
last published: 17/Sep/21 16:05 GMT

back to speakers